BARCLAYS PLC - Y-MABS THERAPEUTICS INC ownership

Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 88 filers reported holding Y-MABS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of Y-MABS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$34
-30.6%
6,302
-13.9%
0.00%
Q2 2023$49
-79.3%
7,317
-84.6%
0.00%
Q1 2023$237
+393.8%
47,409
+380.9%
0.00%
Q4 2022$48
-100.0%
9,859
-84.7%
0.00%
-100.0%
Q3 2022$929,000
+2060.5%
64,445
+2192.6%
0.00%
Q2 2022$43,000
-36.8%
2,811
-51.5%
0.00%
Q1 2022$68,000
-96.5%
5,795
-95.2%
0.00%
Q4 2021$1,944,000
+290.4%
119,956
+586.7%
0.00%
Q3 2021$498,000
+114.7%
17,469
+154.9%
0.00%
Q2 2021$232,000
-77.4%
6,854
-79.8%
0.00%
-100.0%
Q1 2021$1,028,000
+70.8%
34,001
+180.0%
0.00%
Q4 2020$602,000
-67.7%
12,144
-75.0%
0.00%
-100.0%
Q3 2020$1,865,000
-17.0%
48,555
-6.6%
0.00%
-50.0%
Q2 2020$2,247,000
+699.6%
52,004
+382.4%
0.00%
Q1 2020$281,000
-68.0%
10,781
-61.6%
0.00%
Q4 2019$878,000
+165.3%
28,062
+120.9%
0.00%
Q3 2019$331,000
+10.3%
12,701
-3.2%
0.00%
Q2 2019$300,000
-29.6%
13,119
-19.3%
0.00%
Q1 2019$426,000
+102.9%
16,252
+57.2%
0.00%
Q4 2018$210,00010,3390.00%
Other shareholders
Y-MABS THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Sofinnova Investments, Inc. 2,194,278$108,639,0006.47%
Memorial Sloan Kettering Cancer Center 216,916$10,740,0004.55%
Burrage Capital Management LLC 114,962$5,692,0004.34%
MPM BioImpact LLC 674,582$33,398,0002.88%
First Light Asset Management, LLC 635,652$31,471,0002.33%
Cormorant Asset Management, LP 1,661,647$82,268,0001.96%
ASHFORD CAPITAL MANAGEMENT INC 219,419$10,863,0001.05%
ORACLE INVESTMENT MANAGEMENT INC 126,342$6,255,0000.78%
SPHERA FUNDS MANAGEMENT LTD. 131,016$6,487,0000.58%
Artal Group S.A. 285,028$14,112,0000.30%
View complete list of Y-MABS THERAPEUTICS INC shareholders